Community Partner Named 40 Under 40 Leader in Health by National Minority Quality Forum


This year, National Minority Quality Forum (NMQF) recognized one of the Mid-Atlantic Permanente Medical Group’s community partners, Dr. Donney John, PharmD., Executive Director of NOVA ScriptsCentral, Inc. as a “40 Under 40 Leaders in Health” during its annual awards ceremony. Dr. John is a member of both the regional Kaiser Permanente (KP) Research Bank Community Advisory Board and co-chairs the National KP Research Bank Community Advisory Board.

“Delivering exceptional, high quality care to our members is paramount to our mission. We are proud to collaborate with industry leaders such as Dr. John who strive to improve care for individuals in our region, and we congratulate Donney on his accomplishment of being recognized a Top 40 Under 40 Leader in Health”


— Dr. Michael Horberg, Principal Investigator for the Kaiser Permanente Research Bank in the KP Mid-Atlantic States region

The Kaiser Permanente Research Bank is a program that invites KP members to share health information and a small blood sample for health research—with the goal of contributing to future discoveries, treatments, and cures.

“The Kaiser Permanente Research Bank program convenes regional and national Community Advisory Boards to represent the communities we serve and to be vital partners in our effort to improve health. Through these boards, KP members and non-members alike have an opportunity to provide input on a wide range of topics related to medical research,” says Michelle Turner, MPH, who leads the regional Community Advisory Board.

Annually, the National Minority Quality Forum recognizes influential, young, healthcare leaders who are making improvements in health care. In addition to his role as a practicing pharmacist, patient advocate, and entrepreneur, Dr. John contributes to the health of the greater community through his work within the health IT space and his involvement in training health care professionals in health literacy and cultural competency.

In addition to his partnership with the Kaiser Permanente Research Bank, Dr. John and NOVA ScriptsCentral also partnered with Kaiser Permanente Mid-Atlantic States through the Aspirin, Lisinopril, and Lipid-lowering medication (ALL)/Phase Heart Project, which aims to better manage diabetic patients at risk for cardiovascular complications in safety net clinics. He also participated in the award winning Kaiser Permanente Diversity & Health Video Series.

Learn more about the KP Research Bank here:
Announcement from NMQF:

Leave A Reply